Search research articles
Contact Us
Filters
Showing results (421-430 of 426) with videos related to
Page
of 43
Sort By:
You have reached the last page of results.
This site can display upto 426 results.
The Journal of Clinical Investigation
|
September 5, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
Daniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
Nature Communications
|
October 8, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer
Juan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo, et al.
International Journal of Cancer
|
April 12, 2022
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)
Nicholas D James, Noel W Clarke, Adrian Cook, et al.
Cell
|
May 23, 2015
Integrative clinical genomics of advanced prostate cancer
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, et al.
European Urology
|
April 22, 2022
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
Silke Gillessen, Andrew Armstrong, Gert Attard, et al.
European Urology
|
October 11, 2024
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
Silke Gillessen, Fabio Turco, Ian D Davis, et al.
Page
of 43
Search research articles
Search
Showing results (421-430 of 426) with videos related to
Sort By:
Page
of 43
You have reached the last page of results.
This site can display upto 426 results.
The Journal of Clinical Investigation
|
September 5, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
Daniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
Nature Communications
|
October 8, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer
Juan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo, et al.
International Journal of Cancer
|
April 12, 2022
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)
Nicholas D James, Noel W Clarke, Adrian Cook, et al.
Cell
|
May 23, 2015
Integrative clinical genomics of advanced prostate cancer
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, et al.
European Urology
|
April 22, 2022
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
Silke Gillessen, Andrew Armstrong, Gert Attard, et al.
European Urology
|
October 11, 2024
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
Silke Gillessen, Fabio Turco, Ian D Davis, et al.
Page
of 43